Delek US Holdings, Inc. (DK) Refining EBITDA Rose 78% to $1,242.1M

Delek US Holdings (DK) reported Q3 refining EBITDA of $1.24B, up 78% YoY, and logistics EBITDA of $142.9M. The company raised its EOP improvement guidance to $250M and announced up to $100M in Q4 share buybacks. The results included a $334.7M RIN-related cost reduction, which may not recur.

Original reporting
Published Nov 6, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 11:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Delek US Holdings, Inc. (DK) Refining EBITDA Rose 78% to $1,242.1M — source image
Decision brief

The 30-second read

$DKBullishHigh
01

Why it matters

The earnings beat and guidance raise are likely to attract buying interest, especially with a planned $100M buyback in Q4.

02

Market read

Strong earnings and higher guidance provide a clear catalyst for DK stock, with immediate trading relevance.

03

What to watch

Potential volatility in fuel demand and regulatory changes could affect future margins.

Relevance 8/10Novelty 8/10Timing: today

Background

Delek US Holdings, a mid‑cap U.S. refiner, released its Q3 results showing a sharp EBITDA increase and raised its year‑end guidance.

Company-level read

Ticker impact

$DKBullishHigh confidence
Context

Q3 refining EBITDA rose 78% to $1.242B and guidance was raised to at least $250M with up to $100M Q4 buybacks.

Expected impact

upward pressure as investors price in higher earnings and upcoming buybacks

Evidence & confidence

The earnings beat and guidance raise are fresh, material facts that typically drive the stock higher, especially with a announced buyback tranche.

Market effects

Improves outlook for U.S. refining sector as higher margins boost earnings expectations.

Positive for U.S. energy stocks, may lift regional energy indices.

Limited to U.S. energy market; no broad global impact.

Counterpoint

If the RIN cost reduction is non‑recurring, the earnings boost may not be sustainable, suggesting caution.

Key entities

  • Delek US Holdings, Inc.

    U.S. refining and logistics company reporting Q3 results.

Related articles

$DKMed

Why is Delek US stock rallying today?

Delek US Holdings (DK) stock rose 5.1% after an analyst upgrade to Buy with a $88 price target, citing strong Q3 2026 earnings. The company reported adjusted EPS of $13.55 and revenue of $4.39B, exceeding estimates. The board increased the dividend by 18% and authorized $100M in share repurchases. Institutional investors, holding 97% of shares, have been active in recent filings.

$DKHighAI 8/10

Freedom Broker upgrades Delek US stock rating on strong earnings

Freedom Broker upgraded Delek US (NYSE:DK) to Buy, raising its price target to $88. The company reported strong Q3 earnings, with adjusted net income nearly doubling to $843.0 million. DK cut net debt by $506.4 million and increased its dividend by 18%. The stock trades at a P/E ratio of 3.31 with a free cash flow yield of 32%. Raymond James also raised its price target to $95, citing strong macroeconomic conditions and operational improvements.

$DKMedAI 8/10

Delek US Holdings Inc (DK) (Q3 2026) Earnings Call Highlights: Record Net Income, Raised

Delek US Holdings Inc (DK) reported Q3 2026 net income with $809M working capital outflow, $4.6M asphalt segment loss, and no DKTS guidance due to market volatility. CEO Soreq highlighted SRE benefits, cash flow plans, and EOP improvements. Analysts noted RIN uncertainty and El Dorado refinery's low capture rate. The company expects $700M-$800M mid-cycle free cash flow and maintains a disciplined capital allocation strategy.

$DKMedAI 8/10

Delek US Holdings (DK) Q3 2026 Earnings Call Transcript

Delek US Holdings (DK) reported Q3 2026 net income of $1.13B ($18.22/ share) and EBITDA of $1.64B. The company raised its EOP target to $250M annually and expects $425M in SRE proceeds. DKL increased 2026 EBITDA guidance to $530M-$560M. Delek plans $100M in share buybacks and raised its dividend to $0.30/share.